Literature DB >> 2361386

Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter.

M Brenner1, G L Schaer, D L Mallory, A F Suffredini, J E Parrillo.   

Abstract

To evaluate alterations in renal blood flow in sepsis-induced renal failure, we developed and studied a percutaneously placed thermodilution renal blood flow catheter in eight critically ill patients. Para-aminohippurate extraction coefficients were decreased, supporting the need for renal vein sampling to determine CPAH in sepsis. Thermodilution and CPAH methods correlated strongly, confirming the reliability of this thermodilution method. Renal vascular resistance, an indicator of renal vascular function, remained unchanged throughout the bouts of sepsis. The fraction of total body arterial blood flow going to the kidneys rose significantly during recovery from sepsis. Glomerular filtration rate, which was reduced in four of seven septic patients, correlated with the fraction of total blood flow going to the kidneys. These results suggest that renal vascular abnormalities may be occurring during septic shock. Our study demonstrates that sepsis-induced renal dysfunction may occur despite normal ranges of total renal blood flow during shock.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2361386     DOI: 10.1378/chest.98.1.170

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  43 in total

1.  Sepsis-induced acute kidney injury—is there a lack of energy?

Authors:  Robert Frithiof
Journal:  Intensive Care Med       Date:  2012-05       Impact factor: 17.440

Review 2.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 3.  A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

Authors:  Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

Review 4.  Surgical sepsis and organ crosstalk: the role of the kidney.

Authors:  Laura E White; Rahul Chaudhary; Laura J Moore; Frederick A Moore; Heitham T Hassoun
Journal:  J Surg Res       Date:  2010-12-30       Impact factor: 2.192

5.  Renal blood flow and function during recovery from experimental septic acute kidney injury.

Authors:  Christoph Langenberg; Li Wan; Moritoki Egi; Clive N May; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

6.  The multiple organ dysfunction syndrome and late-phase mortality in sepsis.

Authors:  Joshua A Englert; Mitchell P Fink
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

7.  Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.

Authors:  Sean M Bagshaw; Michael Bennett; Michael Haase; Anja Haase-Fielitz; Moritoki Egi; Hiroshi Morimatsu; Giuseppe D'amico; Donna Goldsmith; Prasad Devarajan; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

Review 8.  The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Authors:  Anna Clementi; Grazia Maria Virzì; Alessandra Brocca; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2017-06-24       Impact factor: 2.041

9.  The role of adenosine 1a receptor signaling on GFR early after the induction of sepsis.

Authors:  Jonathan M Street; Erik H Koritzinsky; Tiffany R Bellomo; Xuzhen Hu; Peter S T Yuen; Robert A Star
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

Review 10.  Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies.

Authors:  Sergio Dellepiane; Marita Marengo; Vincenzo Cantaluppi
Journal:  Crit Care       Date:  2016-03-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.